Evidence map›Paper›PMID 41487073›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

HiST: Histological Images Reconstruct Tumor Spatial Transcriptomics via MultiScale Fusion Deep Learning.

Wei Li, Dong Zhang, Eryu Peng, Shijun Shen, Hamid Alinejad-Rokny, Yao Liu, Junke Zheng, Cizhong Jiang, Youqiong Ye

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei LiShanghai Tenth People's Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Dong ZhangShanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Eryu PengShanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shijun ShenShanghai Tenth People's Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Hamid Alinejad-RoknyUNSW BioMedical Machine Learning Lab (BML) School of Biomedical Engineering, UNSW Sydney, Sydney, NSW, Australia.
Yao LiuDepartment of Hepatobiliary Surgery, State Key Laboratory of Immune Response and Immunotherapy, Centre For Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Junke ZhengInstitute for Translational Medicine On Cell Fate and Disease, Shanghai Ninth People's Hospital, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cizhong JiangShanghai Tenth People's Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Youqiong YeShanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0001-8332-4710

Funding

China Postdoctoral Science Foundation 2022M722420Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China JYB2025XDXM611major project in the basic research field of Shanghai Science and Technology Innovation Action Plan 22JC1402302National Basic Research Program of China 2024YFA1803500National key research and development program 2021YFA1100300National key research and development program 2022YFC2504700National key research and development program 2024YFC3407700National Natural Science Foundation of China 32270858National Natural Science Foundation of China 32300478National Natural Science Foundation of China 32470959National Natural Science Foundation of China 32570699National Natural Science Foundation of China 82422058National Natural Science Foundation of China 82430007Research Funds of Centre for Leading Medicine and Advanced Technologies of IHM 2023IHM01032Shanghai Jiao Tong University 2030 Initiative WH510363003/018
6 · The paper itself

Abstract

Spatial transcriptomics (ST) provides valuable insights into the tumor microenvironment by integrating molecular features with spatial context; however, its clinical utility is limited by high costs. To address this, we develop a multi-scale convolutional deep learning framework, HiST, which utilizes ST to learn the relationship between spatially resolved gene expression profiles (GEPs) and histological morphology. HiST accurately predicts tumor regions across multiple cancer types (e.g., breast cancer; area under the curve: 0.96), demonstrating high concordance with pathologist annotations. Moreover, HiST reconstructs spatially resolved GEPs from histological images with an average Pearson correlation coefficient of 0.74 across five cancer types, outperforming existing models by about two-fold. These high-fidelity spatial GEPs enable tumor heterogeneity assessment from histological images, including identification of tumor subtypes with distinct DNA copy number variations. We demonstrate the clinical utility of the predicted GEPs, which robustly stratify patient prognosis across five cancer types from The Cancer Genome Atlas (e.g., breast cancer; concordance index: 0.78). The predicted profiles further facilitate immunotherapy response prediction and enrichment analyses of relevant biological pathways and markers. Collectively, HiST achieves state-of-the-art performance in spatial GEP reconstruction, providing a reliable molecular representation that enhances downstream tasks such as tumor profiling and clinical analyses.

Indexed as

Deep LearningGene Expression ProfilingImage Processing, Computer-AssistedNeoplasmsTranscriptomeBreast NeoplasmsFemaleHumansTumor MicroenvironmentHiSThistological imageprognosis and immunotherapy efficacy predictionspatial transcriptomicstumor spot identification

Identifiers

PMID41487073
PMCPMC12955878

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.